Search details
1.
Normal B-cell ranges in infants: A systematic review and meta-analysis.
J Allergy Clin Immunol
; 150(5): 1216-1224, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35728653
2.
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Eur J Neurol
; 29(4): 1082-1090, 2022 04.
Article
in English
| MEDLINE | ID: mdl-33724638
3.
Comparing the risk of serious infections in patients with and without MS: A German claims data analysis.
Mult Scler Relat Disord
; 72: 104583, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36905817
4.
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records.
Front Neurol
; 14: 1253557, 2023.
Article
in English
| MEDLINE | ID: mdl-38130836
5.
A structured evaluation of cryopreservation in generating single-cell transcriptomes from cerebrospinal fluid.
Cell Rep Methods
; 3(7): 100533, 2023 07 24.
Article
in English
| MEDLINE | ID: mdl-37533636
6.
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis.
J Neurol
; 270(3): 1624-1636, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36469103
7.
An observational study to assess validity and reliability of smartphone sensor-based gait and balance assessments in multiple sclerosis: Floodlight GaitLab protocol.
Digit Health
; 9: 20552076231205284, 2023.
Article
in English
| MEDLINE | ID: mdl-37868156
8.
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Mult Scler Relat Disord
; 68: 104245, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36306609
9.
Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants.
Mult Scler Relat Disord
; 64: 103963, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35753176
10.
COVID-19 in ocrelizumab-treated people with multiple sclerosis.
Mult Scler Relat Disord
; 49: 102725, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33482590
11.
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
Neurology
; 97(16): e1546-e1559, 2021 10 19.
Article
in English
| MEDLINE | ID: mdl-34475123
Results
1 -
11
de 11
1
Next >
>>